Mark Schallenberger
Chief Operating Officer chez XTANT MEDICAL HOLDINGS, INC.
Fortune : 447 753 $ au 31/03/2024
Profil
Mark A.
Schallenberger is currently the Chief Operating Officer at Xtant Medical Holdings, Inc. He previously worked as the Senior Director-Marketing & Product Development at DCI Donor Services Tissue Bank from 2017 to 2019, and as the Chief Operations Officer at Surgenex LLC from 2019 to 2023.
Mr. Schallenberger has a graduate degree from The Scripps Research Institute and an undergraduate degree from The University of Montana.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/04/2024 | 382 695 ( 0,29% ) | 447 753 $ | 31/03/2024 |
Postes actifs de Mark Schallenberger
| Sociétés | Poste | Début |
|---|---|---|
| XTANT MEDICAL HOLDINGS, INC. | Chief Operating Officer | 16/01/2023 |
Anciens postes connus de Mark Schallenberger
| Sociétés | Poste | Fin |
|---|---|---|
| Surgenex LLC | Chief Operating Officer | 01/01/2023 |
| DCI Donor Services Tissue Bank | Corporate Officer/Principal | 01/06/2019 |
Formation de Mark Schallenberger
| The Scripps Research Institute | Graduate Degree |
| The University of Montana | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XTANT MEDICAL HOLDINGS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Surgenex LLC | |
| DCI Donor Services Tissue Bank |
